# Immucell Corp: Form 8-K, filed Mar 18, 2026

- Company: [Immucell Corp](/companies/iccc.md) (CIK 811641)
- Form: 8-K
- Filed: 2026-03-18
- Accepted by EDGAR: Mar 18, 2026, 16:05 ET
- Period: 2026-03-12
- Accession: 0001437749-26-008842
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/811641/000143774926008842/iccc20260318_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/811641/000143774926008842/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/811641/000143774926008842/iccc20260318_8k.htm

Filed Mar 18, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-008842. Last ingested by Listed: Nov 13, 2026, 16:08 ET. No prices; not investment advice.
